Speaker

Prof Bernhard Landwehrmeyer, Ulm University Hospital, Ulm, Germany

Bernhard Landwehrmeyer

Georg Bernhard Landwehrmeyer, MD, FRCP, is a professor of neurology (clinical neurobiology) at Ulm University in the department of neurology where the central coordination of the European Huntington’s Disease Network (EHDN) is situated. Prof Landwehrmeyer was instrumental in founding EHDN in 2004, and served as chairman of the executive committee of EHDN from 2004 to 2014. EHDN serves as a platform for professionals and people affected by Huntington’s disease to work together throughout Europe and conducts large prospective natural history studies in Huntington’s disease—eg, the REGISTRY study. EHDN, as well as REGISTRY, is funded by the CHDI Foundation, USA. Prof Landwehrmeyer received his MD degree and his doctoral degree from the Albert-Ludwigs-University at Freiburg, Germany. Additionally, he was trained at the Royal Victoria Hospital, Queen’s University in Belfast, UK; at the Kantonsspital in Basel, Switzerland; and worked as a post-doc from 1993 to 1996 at MGH, Harvard Medical School, Boston. From 1995 to 1999, he was a staff member at the Albert-Ludwigs-University in Freiburg. In 1999, he received his board certification in neurology and a year later the Venia Legendi and a full professorship (C3) in neurology at the University of Ulm. He has served as principal investigator in several Huntington’s disease trials and is the principal investigator of the CHDI-sponsored Enroll-HD study, a prospective longitudinal observational study on Huntington’s disease and a clinical research platform with a global reach that collects phenotypical clinical data and biomaterials annually from all consenting research participants.

« Go Back

Supporting Publication
Organised by
 
  • Lancet Neurology
  • Elsevier
Silver Sponsor
 
Teva
Sponsors
 
AstraZeneca